Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $434.72 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $134.34 | 2 | $0 (2023) |
| Novo Nordisk Inc | $122.83 | 1 | $0 (2021) |
| PFIZER INC. | $78.40 | 5 | $0 (2024) |
| Gilead Sciences, Inc. | $43.63 | 3 | $0 (2024) |
| Boston Scientific Corporation | $25.27 | 1 | $0 (2024) |
| AbbVie Inc. | $16.63 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $13.62 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.95 | 3 | Boston Scientific Corporation ($25.27) |
| 2023 | $186.19 | 5 | AstraZeneca Pharmaceuticals LP ($121.37) |
| 2022 | $13.22 | 1 | PFIZER INC. ($13.22) |
| 2021 | $148.77 | 3 | Novo Nordisk Inc ($122.83) |
| 2019 | $26.59 | 2 | Janssen Pharmaceuticals, Inc ($13.62) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: COVID-19 | ||||||
| 09/19/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/08/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/24/2023 | PFIZER INC. | VYNDAQEL (Drug), VYNDAMAX | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/02/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $121.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/15/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/08/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/29/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/14/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $122.83 | General |
| Category: Diabetes | ||||||
| 09/23/2021 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: COVID-19 | ||||||
| 08/26/2021 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: COVID-19 | ||||||
| 12/04/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/07/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 653 | 1,125 | $416,972 | $110,352 |
| 2022 | 8 | 596 | 1,215 | $456,297 | $113,591 |
| 2021 | 7 | 606 | 1,102 | $393,439 | $103,848 |
| 2020 | 9 | 759 | 1,331 | $422,641 | $110,051 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 221 | 542 | $185,906 | $54,788 | 29.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 139 | 282 | $67,680 | $18,847 | 27.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 125 | 129 | $94,557 | $18,563 | 19.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 140 | 141 | $50,478 | $13,720 | 27.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 16 | $11,616 | $2,877 | 24.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 15 | $6,735 | $1,557 | 23.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 227 | 731 | $250,733 | $63,047 | 25.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 87 | 90 | $64,630 | $15,169 | 23.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 143 | 148 | $52,984 | $13,496 | 25.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 66 | 153 | $36,720 | $9,328 | 25.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 18 | 35 | $25,410 | $6,473 | 25.5% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 22 | 22 | $14,806 | $3,372 | 22.8% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 19 | 22 | $7,612 | $1,839 | 24.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 14 | 14 | $3,402 | $867.23 | 25.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 229 | 631 | $216,433 | $57,530 | 26.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 77 | 81 | $53,946 | $14,239 | 26.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 143 | 151 | $54,058 | $13,989 | 25.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 98 | 180 | $43,200 | $11,586 | 26.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 28 | 28 | $17,136 | $4,375 | 25.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 20 | 20 | $4,860 | $1,140 | 23.5% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 11 | 11 | $3,806 | $987.36 | 25.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 245 | 636 | $152,640 | $39,280 | 25.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 134 | 307 | $105,101 | $27,650 | 26.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 188 | 196 | $70,001 | $18,139 | 25.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 57 | 57 | $37,962 | $10,180 | 26.8% |
About Roger Saez
Roger Saez is a Internal Medicine healthcare provider based in Hackettstown, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2016. The National Provider Identifier (NPI) number assigned to this provider is 1598118010.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Roger Saez has received a total of $434.72 in payments from pharmaceutical and medical device companies, with $59.95 received in 2024. These payments were reported across 14 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($434.72).
As a Medicare-enrolled provider, Saez has provided services to 2,614 Medicare beneficiaries, totaling 4,773 services with total Medicare billing of $437,841. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Hackettstown, NJ
- Active Since 07/20/2016
- Last Updated 08/20/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598118010
Products in Payments
- LOKELMA (Drug) $134.34
- RYBELSUS (Drug) $122.83
- ELIQUIS (Drug) $61.43
- Veklury (Drug) $43.63
- WATCHMAN FLX (Device) $25.27
- VYNDAQEL (Drug) $16.97
- DALVANCE (Drug) $16.63
- XARELTO (Drug) $13.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hackettstown
Dr. Sanjay Kavathia, M.d, M.D
Internal Medicine — Payments: $16,054
Dr. Sandira Segaram, M.d., F.a.c.p, M.D., F.A.C.P
Internal Medicine — Payments: $9,446
Dr. Lillian Theune, D.o, D.O
Internal Medicine — Payments: $5,606
Keri Ingrassia-Squiers, Do, DO
Internal Medicine — Payments: $4,471
Vineet Sandhu
Internal Medicine — Payments: $3,129
Jimmy Chang, M.d, M.D
Internal Medicine — Payments: $3,000